Feeds
The Food and Drug Administration is warning doctors that a second counterfeit version of the best-selling cancer drug Avastin has been found in the U.S., packaged as the Turkish brand of the medication.
The maker of the widely prescribed cancer drug Avastin is warning doctors and patients about counterfeit vials of the product that have been distributed in the U.S.
Patients with hard-to-treat kidney cancer that has spread to other parts of the body gained a new drug option Friday, after federal regulators approved a twice-a-day pill from Pfizer for the disease.
A key experimental liver cancer drug that Bristol-Myers Squibb Co. has been testing did not meet the main goal of a late-stage study, the company said late Thursday.
A panel of advisers to the Food and Drug Administration voted Wednesday that the benefits of a Pfizer kidney cancer drug outweigh its risks, according to a company spokeswoman.
An independent British medical watchdog says the first treatment proven to help people with the deadliest form of skin cancer is too expensive to be used by the U.K.'s health care system, a recommendation critics called a potential death sentence.
The Food and Drug Administration has approved a new Pfizer drug for a subset of lung cancer patients with a particular genetic mutation.
Federal regulators have approved an innovative cancer drug from Seattle Genetics Inc. to treat two rare forms of cancer that attack the lymph nodes.
Medicare officials confirmed Thursday that the program will cover the $93,000 price tag for prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the disease an extra four months to live.
A panel of cancer experts has ruled for a second time that Avastin, the best-selling cancer drug in the world, should no longer be used in breast cancer patients, clearing the way for the government to remove its endorsement from the drug.
The best-selling cancer drug in the world comes under federal scrutiny once again this week, as drugmaker Roche makes a last-ditch effort to keep Avastin approved for breast cancer, despite the government's opinion that it is ineffective against the disease.
Federal health regulators said Wednesday they have approved a new drug from AstraZeneca to treat a rare form of thyroid cancer that can be fatal when it spreads to other parts of the body.
Medicare officials said Wednesday that the program will pay the $93,000 cost of prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the disease an extra four months to live.
The Food and Drug Administration has granted Swiss drugmaker Roche a first-of-a-kind public hearing to defend the effectiveness of its drug Avastin for treating breast cancer, just months after the agency ruled that the drug is ineffective for that use.
A new analysis raises fresh questions about the risks of the blockbuster cancer drug Avastin, suggesting the chance of dying from side effects linked to it is higher than the risk for patients on chemotherapy alone.
French drugmaker Sanofi-Aventis SA said Thursday a clinical trial showed its drug candidate iniparib did not improve survival or slow disease progression in patients with breast cancer.
Federal health authorities recommended Thursday that the blockbuster drug Avastin no longer be used to treat breast cancer, saying recent studies failed to show the drug's original promise to help slow the disease and extend patients' lives.
Drugmaker Roche said Friday that U.S. health regulators will take more time to review its drug Avastin for breast cancer, a use that has generated vigorous debate among cancer specialists and patients.
The Food and Drug Administration on Thursday approved the first prostate cancer chemotherapy drug found to extend the survival of men who are no longer being helped by other treatments.
Swiss drug maker Novartis AG said Thursday it won't ask regulators for permission to market a new ovarian cancer drug after a late-stage trial proved disappointing.
Genentech's blockbuster blood cancer drug Rituxan was approved Thursday for a new use by the Food and Drug Administration.
Federal health advisers said Monday an experimental kidney cancer drug from GlaxoSmithKline PLC can benefit patients by slowing the disease, despite some risk of liver damage.
The Food and Drug Administration has approved the first drug made specifically to treat cancer in dogs.
Pfizer Inc. said Thursday it ended a successful trial of its cancer drug Sutent early after data showed the drug met its goal of slowing the progression of pancreatic cancer.
A court has rejected a British woman's plea for the country's health service to provide her with the breast cancer drug Herceptin.
Cancer drug erases man's fingerprints, doctor says A Singapore man undergoing treatment for cancer was detained for four hours by U.S.
Dr. Michel Obeid of Lebanon discovers major cancer drugDr. Michel Obeid of Lebanon discovers major cancer drug Sunday, 18 March, 2007 @ 5:16 PM
New Drug Approved for Stomach and Kidney CancerA new drug has been approved to treat both advanced kidney cancer and a rare form of stomach cancer when other therapies fail to help.
Log In | Register